The Czechoslovak Group rolled out its CFL-120 Karpat light tank at the IDEB 2026 defence exhibition in Bratislava this week, but the buzz from the product launch has done little to arrest the slide in its stock. At Friday’s close of €16.42, the shares are trading just 4.4% above their 52-week nadir and a staggering 51% below the January peak of €33.81. The annualised volatility stands at nearly 73% — a figure that underscores frayed investor nerves as the company prepares to deliver its first quarterly report since listing.
That earnings release, due on Wednesday, will be more than a routine financial update. It marks the maiden opportunity for management to prove that the operational muscle underpinning the group can translate into the kind of cash generation and margin discipline that markets demand. The backdrop is a complex one: a fresh strategic partnership on a new armoured vehicle, a simmering delivery dispute on a key artillery contract, and a looming deadline for a €58 billion munitions framework that still lacks a financing backer.
Operationally, the numbers from last year look solid on paper. CSG grew revenue by nearly 72% in 2025 to €6.7 billion, fuelled by both organic expansion and acquisitions. Its order book has swelled to €42 billion, providing rare long-term revenue visibility. For the current year, management has guided for sales of €7.4 billion to €7.6 billion and an adjusted operating EBIT margin of 24% to 25%. The question hanging over Wednesday’s report is how deeply one-off costs from the initial public offering will gouge that margin — and whether free cash flow will justify the bulging order pipeline.
Free cash flow is the metric analysts are zeroing in on. A €42 billion backlog only reassures if orders are converting into hard cash, and the market is already sensitive to execution risk. That sensitivity is amplified by the ongoing dispute over 62 Caesar howitzers destined for the Czech Republic. The €10.3 billion Czech crown order has stalled because of a disagreement between partner KNDS and the Czech defence ministry, blocking formal acceptance of the systems. Until that snag is untangled, the delivery delay hangs over CSG’s near-term revenue recognition.
The Karpat tank, meanwhile, represents a longer-term bet. Developed with Turkey’s FNSS and armed with a Leonardo HITFACT® MkII 120mm turret, the 34-tonne vehicle can reach 70 km/h and has a range of roughly 450 kilometres. CSG is implicitly positioning it for a future Slovak army procurement competition, and the timing of the IDEB debut was no coincidence. Yet new products alone cannot shift a share price that has dropped 22.7% in a single month. The market needs to see orders convert into actual deliveries.
Should investors sell immediately? Or is it worth buying CSG?
Analyst sentiment remains bullish despite the stock’s travails. JPMorgan has a €40 price target, and the consensus of nine analysts stands at €35.40, with every one of them rating the shares a buy. That optimistic consensus sits uneasily beside a price that has more than halved since January, suggesting a wide gulf between Wall Street’s view of CSG’s intrinsic value and the caution portfolio managers currently display.
Beyond Wednesday’s numbers, the next big event for the group is the end-of-month deadline for its Slovak munitions framework agreement. The framework, potentially worth up to €58 billion, can be financed via the EU’s SAFE programme at a 1% interest rate — but only if at least two EU member states sign up. So far, Romania has denied any ministerial-level talks, and Croatia is still weighing participation. Should Bratislava fail to find a partner, higher financing costs could delay future orders.
CSG is not waiting idly for clarity. In March it announced the acquisition of a 49% stake in Austrian ammunition specialist Hirtenberger Defence Systems — a deal awaiting regulatory approval that could serve as a near-term catalyst. It has also signed a framework agreement with Poland’s PGZ to collaborate on ammunition, unmanned systems, and land platforms. Meanwhile, the Slovak government has pledged to significantly expand its artillery munition deliveries to Ukraine, a move that underscores the geopolitical tailwind for the region’s defence industry.
Wednesday’s numbers, then, are a test not just of earnings discipline but of credibility. If management can show that IPO-related costs are temporary and that free cash flow is starting to flow from the backlog, the gap between operational strength and stock-market valuation may begin to narrow. But without a partner for the SAFE-financed Slovak programme, and with the Caesar dispute unresolved, the uncertainty that has driven the shares to near-record lows will not evaporate overnight.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from May 17 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 17.
CSG: Buy or sell? Read more here...
